Newsletter - September 1st, 2021
Developmental Training Course Launch
We’re excited to have launched a dedicated Teachable training course specifically covering the GX Sciences Developmental Panel. Intended for providers and partners that would like to gain a deeper understanding of our Developmental panel; the course includes one complimentary test kit to try on themselves or a patient for personalized learning.
TeloTest™ Pre-Orders Now Open
TeloTest™ is now available for pre-order in bulk to registered GX Providers via the Provider Portal in the “Orderable Products” section! Up to ~50% in “Early-Bird” savings can be reserved during the pre-order and rollout phase, so act now as this offer won’t last long. As a reminder – TeloTest™ will offer a unique, innovative, and scientific perspective of how each of us age, coupled with the relevance of our DNA via each person’s unique telomere length. We plan to gradually rollout the TeloTest™ to select providers starting later this month. More details will be provided in the coming weeks, including full sample reports, brochures, training, and more. If you’re a provider that’s interested in being one of the first to try and offer the TeloTest™ – pre-order today or contact us to learn more.
Lab Status Update - July 2021
In order to convey further transparency to our valued clients and contacts, GX Sciences is proud to include a monthly Lab Turnaround Time status update on the newsletter preceding the previous month. We’ll include the monthly average turnaround time (TAT) and the monthly median measured in business days.
GX Sciences’s Average Turnaround time in July 2021 was 7.1 business days, while the Median was 6 business days. Our goal is 5-7 business days.*
*Lab turnaround time is calculated starting at the time a valid sample is received and all subsequent forms are received correctly. Low concentrations in a sample adds time required to prevent sample recollection. Accounts for potential for one or more SNPs to be rerun to rectify NOAMP or UND calls.
Panel Focus: Developmental
Why is it relevant?
In the United States, 1 in 5 children have learning and attention issues. Genetics, toxin exposure and adverse childhood experiences have an influence on the development of learning and attention deficits (Source). With the start of school, it is important to identify and assess genetic predispositions to developmental issues. GX Sciences strives to educate our practitioners about genetic and environmental factors that could explain symptoms associated with various developmental disorders.
Why is it important?
In the United States, 1 in 6 children have a developmental difference. Our comprehensive nutrigenomic panel, Developmental, identifies underlying contributing factors to spectrum disorders, childhood attention disorders, speech delay, reading, writing, and counting/math trouble, auditory disorders, and seizure related disorders.
This genetic test contains 34 gene variants (SNPs) that play a significant role in developmental issues. Genetic findings and interpretations through the GX Sciences supplementation algorithm can help determine:
- Insufficiencies in Methylation Pathways
- Genetic Factors Contributing to Mood, Anxiety and/or Focus Issues
- Insufficiencies in Neurogenesis
- Autophagy Efficacy Within High Energy Cells Involved in the Nervous, Immune & Endocrine System
- Susceptibility of Sugar-Induced Hyperactivity
- Potential Inflammation Stimulators from the Environment
- The Body’s Ability to Detox
Key Genes Related to Developmental
ADARA2
The ADRA2A (Adrenergic Receptor Alpha 2A) gene determines sensitivity of the adrenergic nervous system response. ADARA2 regulates the release of neurotransmitter molecules from sympathetic nerves. Individuals with the G allele at this location were predicted to be at higher risk of sugar-induced hyperactivity. However, patients with this SNP may also have a better response to ADHD treatment with typical pharmacological interventions. Studies show that poor executive function (memory, flexible thinking, and self-control) is also associated with ADRA2A. (Source)
CTH
Glutathione production is dependent on the function of the enzyme cystathionine gamma-lyase (CTH). Glutathione is known as the body’s #1 antioxidant. Glutathione conjugation helps to detoxify and eliminate toxins in the liver, lungs, intestines, and kidneys. Individuals with mutations in the CTH gene are predicted to have decreased glutathione-mediated detoxification. Studies show that subjects diagnosed with an autism spectrum disorder (ASD) have significantly lower glutathione levels than typically developing children limiting their ability to detoxify. (Source)
GAD1
Glutathione production is dependent on the function of the enzyme cystathionine gamma-lyase (CTH). Glutathione is known as the body’s #1 antioxidant. Glutathione conjugation helps to detoxify and eliminate toxins in the liver, lungs, intestines, and kidneys. Individuals with mutations in the CTH gene are predicted to have decreased glutathione-mediated detoxification. Studies show that subjects diagnosed with an autism spectrum disorder (ASD) have significantly lower glutathione levels than typically developing children limiting their ability to detoxify. (Source)
Registered? Order test kits, view sample reports, access resources, and more via our portal
Not registered yet? Submit our online registration form with your credentials and gain provider access
Want to learn more to see if GX Sciences testing is right for your practice? Schedule a consultation today